These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16500716)

  • 41. Fragile X mental retardation protein regulates olfactory sensitivity but not odorant discrimination.
    Schilit Nitenson A; Stackpole EE; Truszkowski TL; Midroit M; Fallon JR; Bath KG
    Chem Senses; 2015 Jun; 40(5):345-50. PubMed ID: 25917509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Limbic epileptogenesis in a mouse model of fragile X syndrome.
    Qiu LF; Lu TJ; Hu XL; Yi YH; Liao WP; Xiong ZQ
    Cereb Cortex; 2009 Jul; 19(7):1504-14. PubMed ID: 18832330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered Connectivity and Synapse Maturation of the Hippocampal Mossy Fiber Pathway in a Mouse Model of the Fragile X Syndrome.
    Scharkowski F; Frotscher M; Lutz D; Korte M; Michaelsen-Preusse K
    Cereb Cortex; 2018 Mar; 28(3):852-867. PubMed ID: 28077511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
    Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
    Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
    Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
    Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.
    Louhivuori V; Vicario A; Uutela M; Rantamäki T; Louhivuori LM; Castrén E; Tongiorgi E; Akerman KE; Castrén ML
    Neurobiol Dis; 2011 Feb; 41(2):469-80. PubMed ID: 21047554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corticosterone response to acute stress in a mouse model of Fragile X syndrome.
    Markham JA; Beckel-Mitchener AC; Estrada CM; Greenough WT
    Psychoneuroendocrinology; 2006 Jul; 31(6):781-5. PubMed ID: 16621323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Primary Ciliary Deficits in Cerebellar Bergmann Glia of the Mouse Model of Fragile X Syndrome.
    Lee B; Beuhler L; Lee HY
    Cerebellum; 2022 Oct; 21(5):801-813. PubMed ID: 35438410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated progranulin contributes to synaptic and learning deficit due to loss of fragile X mental retardation protein.
    Zhang K; Li YJ; Guo Y; Zheng KY; Yang Q; Yang L; Wang XS; Song Q; Chen T; Zhuo M; Zhao MG
    Brain; 2017 Dec; 140(12):3215-3232. PubMed ID: 29096020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spatiotemporal expression of PSD-95 in Fmr1 knockout mice brain.
    Zhu ZW; Xu Q; Zhao ZY; Gu WZ; Wu DW
    Neuropathology; 2011 Jun; 31(3):223-9. PubMed ID: 21092061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of the postsynaptic density in the pathology of the fragile X syndrome.
    Kindler S; Kreienkamp HJ
    Results Probl Cell Differ; 2012; 54():61-80. PubMed ID: 22009348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Linking the Fragile X mental retardation protein to the lipoxygenase pathway.
    Beaulieu MA
    Med Hypotheses; 2013 Mar; 80(3):289-91. PubMed ID: 23313071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice.
    Levenga J; de Vrij FM; Buijsen RA; Li T; Nieuwenhuizen IM; Pop A; Oostra BA; Willemsen R
    Neurobiol Learn Mem; 2011 May; 95(4):467-72. PubMed ID: 21371563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The molecular biology of FMRP: new insights into fragile X syndrome.
    Richter JD; Zhao X
    Nat Rev Neurosci; 2021 Apr; 22(4):209-222. PubMed ID: 33608673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.
    Lu P; Chen X; Feng Y; Zeng Q; Jiang C; Zhu X; Fan G; Xue Z
    Sci China Life Sci; 2016 Nov; 59(11):1093-1105. PubMed ID: 27730449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of the fragile X mental retardation protein causes aberrant differentiation in human neural progenitor cells.
    Sunamura N; Iwashita S; Enomoto K; Kadoshima T; Isono F
    Sci Rep; 2018 Aug; 8(1):11585. PubMed ID: 30072797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatosensory map expansion and altered processing of tactile inputs in a mouse model of fragile X syndrome.
    Juczewski K; von Richthofen H; Bagni C; Celikel T; Fisone G; Krieger P
    Neurobiol Dis; 2016 Dec; 96():201-215. PubMed ID: 27616423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tracking the Fragile X Mental Retardation Protein in a Highly Ordered Neuronal RiboNucleoParticles Population: A Link between Stalled Polyribosomes and RNA Granules.
    El Fatimy R; Davidovic L; Tremblay S; Jaglin X; Dury A; Robert C; De Koninck P; Khandjian EW
    PLoS Genet; 2016 Jul; 12(7):e1006192. PubMed ID: 27462983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome.
    Dahlhaus R; El-Husseini A
    Behav Brain Res; 2010 Mar; 208(1):96-105. PubMed ID: 19932134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.
    Prieto M; Folci A; Martin S
    Mol Psychiatry; 2020 Aug; 25(8):1688-1703. PubMed ID: 31822816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.